Diagnosing a company's overseas position

Most overseas advice starts from the market: which country is growing, which channel is hot. That order is backwards. Market conditions are the same for everyone; whether they can be used at all depends on what this company currently is.

So the first step is to lay out the starting facts. Which products have real purchases and repeat purchases behind them. Where the margin and the cash actually come from. What the strongest capability is, and what the most fragile link is. And what overseas growth is being asked to deliver: new market, risk spread, capacity absorption or brand position.

That last question sounds abstract and decides everything downstream. A company going overseas to absorb capacity and one going overseas to spread risk will choose different routes into the same country, and should accept different definitions of failure.

Attractiveness and preference are two different things, and merging them is the most common failure in entry decisions. A large market does not mean this company should enter it. A country the owner knows and likes does not mean a workable route into it exists.

The diagnosis separates four things: the market and industry opportunity; the fit between the product and the actual use case; the company's own preferences on region, timing, risk and strategy; and the points where preference and constraint are in conflict.

The fourth is where the value is. Once the conflicts are written down explicitly, the conversation stops being whether this country is good and becomes what we would have to give up, and what we would have to build, to enter it. That is a question an owner can actually decide.

Within one country there can be distribution, agency, platform, direct sales, project cooperation, OEM/ODM and a local entity, and their thresholds, speed, degree of control and required investment are entirely different. So the unit of analysis is country times route times condition, not a ranked list of countries.

A report containing only a country ranking looks like a conclusion while leaving the hardest part to the client: in what capacity you enter, who you sell to, who delivers, and who carries the liability when something fails. Until those are settled, the right country still goes nowhere.

Compliance: product standards, trade rules, sanctions, data requirements, certification and industry regulation.

Supply chain: production, warehousing, transport, installation, after-sales and spare parts.

Organisation: an accountable owner, cross-cultural working, decision speed and governance capacity.

Finance and tax: funding path, tax cost, collection, currency exposure and cash cycle.

These are gates, not scored criteria. A gate means: if it is not met, the route stops, and a high attractiveness score does not buy it back. Where evidence is thin the correct action is to stop short of a firm conclusion rather than average the gap away. Averaging makes a report look complete at the cost of the client not knowing where they are actually stuck.

A usable diagnosis contains candidate markets and candidate routes; a priority wave and a reserve wave; the preconditions, hard gates and capability gaps of each route; the cheapest validation action available next; and the conditions under which to continue, pause or exit.

Note the last item. Most entry plans describe how to go in and never describe when to stop. A plan without exit conditions becomes, at the point of failure, a defence of sunk cost rather than a basis for deciding.

This framework does not replace legal, tax, certification, sanctions or investment advice, and it does not reduce the question to a single score. Its job is to leave every step of the judgement open to inspection afterwards.